Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as ...

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...

Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous ...

Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations ...

a novel oral drug that targets the neuromuscular root cause of airway obstruction in sleep apnea and holds promise for transforming care for a broad range of patients.” Full results from the ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.

Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of ...